DACH1 Antibodies

Santa Cruz Biotechnology delivers a wide array of DACH1 monoclonal antibodies for investigating DACH1 in various biological processes. DACH1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DACH1, or Dachshund homolog 1, functions as a crucial transcriptional regulator involved in developmental processes and cellular differentiation. DACH1 plays a significant role in the regulation of gene expression and has been linked to various diseases, including cancer. Research has shown that DACH1 influences multiple cellular signaling pathways, making it a potential therapeutic target. Investigating DACH1 expression and activity patterns can provide valuable information about its role in normal development and disease progression. Understanding DACH1 function continues to be an active area of research in developmental biology and cancer studies. Exploring DACH1's molecular mechanisms can reveal new therapeutic strategies for treating related disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of DACH1's role in human health and disease.